Deal Type
Deal Type
Vital Sector
Completion Date
Completion Date
10th October 2023
Deal Value
Deal Value
Not disclosed

Company Background

Founded in 2013, Kolinpharma was listed on the Euronext Growth Milan multilateral trading system since 2018. The company specializes in the research and development of nutraceutical products to support pharmacological treatments for pathologies in orthopedics-physiatry and urology-gynecology. Kolinpharma’s products also stand out for their marked innovation and attention to environmental and ESG policies.

Deal Summary

Ethica Group, with the M&A Advisory and Debt Advisory teams, assisted Igea Holding, a vehicle controlled by Hyle Capital Partners, in the voluntary takeover bid for Kolinpharma, a leading Italian company in nutraceuticals.

Kolinpharma deal contacts

Key members of the Ethica Group deal team crucial in the Kolinpharma transaction

Beatrice Serina

Ethica Group